{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,3]],"date-time":"2025-11-03T09:16:14Z","timestamp":1762161374488},"reference-count":19,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2018,7,13]],"date-time":"2018-07-13T00:00:00Z","timestamp":1531440000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"GNT Pharma"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Trials"],"published-print":{"date-parts":[[2018,12]]},"DOI":"10.1186\/s13063-018-2746-9","type":"journal-article","created":{"date-parts":[[2018,7,13]],"date-time":"2018-07-13T13:18:22Z","timestamp":1531487902000},"update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":23,"title":["Safety and Optimal Neuroprotection of neu2000 in acute Ischemic stroke with reCanalization: study protocol for a randomized, double-blinded, placebo-controlled, phase-II trial"],"prefix":"10.1186","volume":"19","author":[{"name":"on the behalf of the SONIC investigators","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ji Man","family":"Hong","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mun Hee","family":"Choi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sung-Il","family":"Sohn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yang-Ha","family":"Hwang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Seong Hwan","family":"Ahn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yeong-Bae","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dong-Ick","family":"Shin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"\u00c1ngel","family":"Chamorro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dennis W.","family":"Choi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2018,7,13]]},"reference":[{"key":"2746_CR1","doi-asserted-by":"publisher","first-page":"846","DOI":"10.1016\/S1474-4422(15)00140-4","volume":"14","author":"BCV Campbell","year":"2015","unstructured":"Campbell BCV, Donnan GA, Lees KR, Hacke W, Khatri P, Hill MD, et al. Endovascular stent thrombectomy: the new standard of care for large vessel ischaemic stroke. Lancet Neurol. 2015;14:846\u201354.","journal-title":"Lancet Neurol"},{"key":"2746_CR2","doi-asserted-by":"publisher","first-page":"1723","DOI":"10.1016\/S0140-6736(16)00163-X","volume":"387","author":"M Goyal","year":"2016","unstructured":"Goyal M, Menon BK, van Zwam WH, Dippel DW, Mitchell PJ, Demchuk AM, et al. Endovascular thrombectomy after large-vessel ischaemic stroke: a meta-analysis of individual patient data from five randomised trials. Lancet. 2016;387:1723\u201331.","journal-title":"Lancet"},{"key":"2746_CR3","doi-asserted-by":"publisher","first-page":"869","DOI":"10.1016\/S1474-4422(16)00114-9","volume":"15","author":"A Chamorro","year":"2016","unstructured":"Chamorro A, Dirnagl U, Urra X, Planas AM. Neuroprotection in acute stroke: targeting excitotoxicity, oxidative and nitrosative stress, and inflammation. Lancet Neurol. 2016;15:869\u201381.","journal-title":"Lancet Neurol"},{"key":"2746_CR4","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1016\/j.pneurobio.2013.11.006","volume":"115","author":"TW Lai","year":"2014","unstructured":"Lai TW, Zhang S, Wang YT. Excitotoxicity and stroke: identifying novel targets for neuroprotection. Prog Neurobiol. 2014;115:157\u201388.","journal-title":"Prog Neurobiol"},{"key":"2746_CR5","doi-asserted-by":"publisher","first-page":"2123","DOI":"10.1161\/01.STR.0000025518.34157.51","volume":"33","author":"DJ Gladstone","year":"2002","unstructured":"Gladstone DJ, Black SE, Hakim AM, et al. Toward wisdom from failure: lessons from neuroprotective stroke trials and new therapeutic directions. Stroke. 2002;33:2123\u201336.","journal-title":"Stroke"},{"key":"2746_CR6","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1002\/ana.24528","volume":"79","author":"M Goyal","year":"2016","unstructured":"Goyal M, Hill MD, Saver JL, Fisher M. Challenges and opportunities of endovascular stroke therapy. Ann Neurol. 2016;79:11\u20137.","journal-title":"Ann Neurol"},{"key":"2746_CR7","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1056\/NEJMoa003289","volume":"346","author":"SA Bernard","year":"2002","unstructured":"Bernard SA, Gray TW, Buist MD, Jones BM, Silvester W, Gutteridge G, et al. Treatment of comatose survivors of out-of-hospital cardiac arrest with induced hypothermia. N Engl J Med. 2002;346:557\u201363.","journal-title":"N Engl J Med"},{"key":"2746_CR8","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1161\/STROKEAHA.113.003143","volume":"45","author":"JM Hong","year":"2014","unstructured":"Hong JM, Lee JS, Song HJ, Jeong HS, Choi HA, Lee K. Therapeutic hypothermia after recanalization in patients with acute ischemic stroke. Stroke. 2014;45:134\u201340.","journal-title":"Stroke"},{"key":"2746_CR9","doi-asserted-by":"publisher","first-page":"1142","DOI":"10.1038\/sj.jcbfm.9600418","volume":"27","author":"BJ Gwag","year":"2007","unstructured":"Gwag BJ, Lee YA, Ko SY, Lee MJ, Im DS, Yun BS, et al. Marked prevention of ischemic brain injury by Neu2000, an NMDA antagonist and antioxidant derived from aspirin and sulfasalazine. J Cereb Blood Flow Metab. 2007;27:1142\u201351.","journal-title":"J Cereb Blood Flow Metab"},{"key":"2746_CR10","doi-asserted-by":"publisher","first-page":"788","DOI":"10.1016\/j.tiv.2012.12.011","volume":"27","author":"NP Visavadiya","year":"2013","unstructured":"Visavadiya NP, McEwen ML, Pandya JD, Sullivan PG, Gwag BJ, Springer JE. Antioxidant properties of Neu2000 on mitochondrial free radicals and oxidative damage. Toxicol in Vitro. 2013;27:788\u201397.","journal-title":"Toxicol in Vitro"},{"key":"2746_CR11","doi-asserted-by":"publisher","first-page":"A7","DOI":"10.1038\/399a007","volume":"399","author":"JM Lee","year":"1999","unstructured":"Lee JM, Zipfel GJ, Choi DW. The changing landscape of ischaemic brain injury mechanisms. Nature. 1999;399:A7\u201314.","journal-title":"Nature"},{"key":"2746_CR12","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1007\/s00401-010-0785-8","volume":"121","author":"UJ Park","year":"2011","unstructured":"Park UJ, Lee YA, Won SM, Lee JH, Kang SH, Springer JE, et al. Blood-derived iron mediates free radical production and neuronal death in the hippocampal CA1 area following transient forebrain ischemia in rat. Acta Neuropathol. 2011;121:459\u201373.","journal-title":"Acta Neuropathol"},{"key":"2746_CR13","doi-asserted-by":"publisher","first-page":"121","DOI":"10.3858\/emm.2011.43.2.020","volume":"43","author":"SM Won","year":"2011","unstructured":"Won SM, Lee JH, Park UJ, Gwag J, Gwag BJ, Lee YB. Iron mediates endothelial cell damage and blood-brain barrier opening in the hippocampus after transient forebrain ischemia in rats. Exp Mol Med. 2011;43:121\u20138.","journal-title":"Exp Mol Med"},{"key":"2746_CR14","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1358\/dnp.2010.23.9.1513493","volume":"23","author":"SI Cho","year":"2010","unstructured":"Cho SI, Park UJ, Chung JM, Gwag BJ. Neu2000, an NR2B-selective, moderate NMDA receptor antagonist and potent spin trapping molecule for stroke. Drug News Perspect. 2010;23:549\u201356.","journal-title":"Drug News Perspect"},{"key":"2746_CR15","doi-asserted-by":"publisher","first-page":"102","DOI":"10.5853\/jos.2015.01655","volume":"18","author":"KS Hong","year":"2016","unstructured":"Hong KS, Ko SB, Yu KH, Jung C, Park SQ, Kim BM, et al. Update of the Korean clinical practice guidelines for endovascular recanalization therapy in patients with acute ischemic stroke. J Stroke. 2016;18:102\u201313.","journal-title":"J Stroke"},{"key":"2746_CR16","doi-asserted-by":"publisher","first-page":"1317","DOI":"10.1056\/NEJMoa0804656","volume":"359","author":"W Hacke","year":"2008","unstructured":"Hacke W, Kaste M, Bluhmki E, Brozman M, D\u00e1valos A, Guidetti D, et al. Thrombolysis with alteplase 3 to 4.5 hours after acute ischemic stroke. N Engl J Med. 2008;359:1317\u201329.","journal-title":"N Engl J Med"},{"key":"2746_CR17","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1056\/NEJMoa1411587","volume":"372","author":"OA Berkhemer","year":"2015","unstructured":"Berkhemer OA, Fransen PS, Beumer D, van den Berg LA, Lingsma HF, Yoo AJ, et al. A randomized trial of intraarterial treatment for acute ischemic stroke. N Engl J Med. 2015;372:11\u201320.","journal-title":"N Engl J Med"},{"key":"2746_CR18","doi-asserted-by":"publisher","first-page":"1019","DOI":"10.1056\/NEJMoa1414905","volume":"372","author":"M Goyal","year":"2015","unstructured":"Goyal M, Demchuk AM, Menon BK, Eesa M, Rempel JL, Thornton J, et al. Randomized assessment of rapid endovascular treatment of ischemic stroke. N Engl J Med. 2015;372:1019\u201330.","journal-title":"N Engl J Med"},{"key":"2746_CR19","doi-asserted-by":"publisher","first-page":"S111","DOI":"10.1161\/STROKEAHA.108.528877","volume":"40","author":"MD Ginsberg","year":"2009","unstructured":"Ginsberg MD. Current status of neuroprotection for cerebral ischemia: synoptic overview. Stroke. 2009;40:S111\u20134.","journal-title":"Stroke"}],"container-title":["Trials"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13063-018-2746-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s13063-018-2746-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13063-018-2746-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,7,12]],"date-time":"2019-07-12T23:16:05Z","timestamp":1562973365000},"score":1,"resource":{"primary":{"URL":"https:\/\/trialsjournal.biomedcentral.com\/articles\/10.1186\/s13063-018-2746-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,7,13]]},"references-count":19,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018,12]]}},"alternative-id":["2746"],"URL":"https:\/\/doi.org\/10.1186\/s13063-018-2746-9","relation":{},"ISSN":["1745-6215"],"issn-type":[{"type":"electronic","value":"1745-6215"}],"subject":[],"published":{"date-parts":[[2018,7,13]]},"assertion":[{"value":"19 February 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 June 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 July 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The SONIC trial will be conducted according to the ethical principles of the Declaration of Helsinki. Written informed consent will be obtained from the patient or a legal representative before enrollment. The trial protocol has been reviewed and approved for the Republic of Korea by the Ministry of Food and Drug Safety on 29 April 2016 (number 11771) and received ethical approval from the Institutional Review Board of Ajou University Medical Center and each clinical sites.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Publisher\u2019s Note"}}],"article-number":"375"}}